微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: The mystery of Moderna’s magic algorithm
RSS 官方收录 · 可信分层展示
关键摘要
A personalized cancer vaccine developed by Moderna and Merck has generated widespread enthusiasm since the companies announced last week that it had succeeded in a late-stage trial.…
- If regulators ultimately approve it, the treatment will be a triumph o…
- But it may also be a triumph of the algorithm.
- The vaccine, intismeran autogene, would be the first approved medicine…
摘要引擎：抽取
正文提要
A personalized cancer vaccine developed by Moderna and Merck has generated widespread enthusiasm since the companies announced last week that it had succeeded in a late-stage trial. If regulators ultimately approve it, the treatment will be a triumph of immunology and cancer biology.
But it may also be a triumph of the algorithm.
The vaccine, intismeran autogene, would be the first approved medicine whose genetic instructions — that is, the individual letters of its mRNA — is determined by a computer.